Target intelligence / Profile preview

Coagulation Factor VII (Activated) (FVIIa)

Target
FVIIa
Molecular classification
Serine protease, Vitamin K-dependent glycoprotein, Enzyme
01

Overview

Coagulation factor VII (activated), or FVIIa, is a serine protease that initiates blood coagulation by forming a complex with tissue factor (TF). This complex activates factors IX and X, leading to thrombin generation and fibrin clot formation. Recombinant human FVIIa (rFVIIa) is used therapeutically to treat bleeding episodes in patients with hemophilia and other clotting disorders.

Other names
Factor VIIaFVIIaActivated Factor VIIEptacog alfa (activated)
02

Mechanism of action

Binds to tissue factor, forming a complex that activates factors IX and X, leading to thrombin generation and clot formation.

03

Biological functions

HemostasisBlood coagulationActivation of coagulation factors IX and X
04

Disease associations

Hemophilia AHemophilia BCongenital Factor VII deficiencyAcquired HemophiliaGlanzmann's ThrombastheniaBleeding disorders
05

Safety considerations

Thromboembolic events
06

Interacting drugs

NovoSeven

2 more in the full profile.

Beyond the preview

Go deeper on Coagulation Factor VII (Activated) (FVIIa).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coagulation Factor VII (Activated) (FVIIa).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call